Products for Research Use Only
RegisterLogin

KRASG12C IN-17

CAT: 0804-HY-179403Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-179403Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KRASG12C IN-17 is an orally active covalent KRASG12C inhibitor, showing strong inhibitory activity in KRASG12C-mutant cancer cells (NCI-H23 IC50 = 0.7 nM; NCI-H358 IC50 = 0.5 nM) . KRASG12C IN-17 covalently and irreversibly binds to KRASG12C with > 96% modification efficiency in both GDP-bound and GMPPNP-bound conformations. KRASG12C IN-17 can be used for studies of KRAS-driven cancers, including colorectal cancer[1].
CAS Number
2966924-23-0
UNSPSC
12352005
Target
Ras
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Field of Research
Cancer
Smiles
N#CC[C@@H]1N(C(C(F)=C)=O)CCN(C2=C3C=C(F)C(C4=C5C(C#C)=CC=CC5=CC=C4)=C(F)C3=NC(OCC67CCCN6CCC7)=N2)C1
Molecular Formula
C37H33F3N6O2
Molecular Weight
650.69
References & Citations
[1]Gao K, et al. Structure-based design and synthesis of novel highly potent and selective KRASG12C inhibitors. Eur J Med Chem. 2026;302 (Pt 2) :118321. doi:10.1016/j.ejmech.2025.118321
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras

Chemical Information

Krasg12C IN-17
CAS Number2966924-23-0
PubChem CID169131470
IUPAC Name2-[(2S)-4-[7-(8-ethynylnaphthalen-1-yl)-6,8-difluoro-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)quinazolin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile
Molecular FormulaC37H33F3N6O2
Molecular Weight650.7
XLogP6.5
Topological Polar Surface Area85.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count10
Rotatable Bond Count8
Heavy Atom Count48
Formal Charge0
Complexity1300
SMILES
C=C(C(=O)N1CCN(C[C@@H]1CC#N)C2=NC(=NC3=C(C(=C(C=C32)F)C4=CC=CC5=C4C(=CC=C5)C#C)F)OCC67CCCN6CCC7)F
InChI
InChI=1S/C37H33F3N6O2/c1-3-24-8-4-9-25-10-5-11-27(30(24)25)31-29(39)20-28-33(32(31)40)42-36(48-22-37-13-6-16-45(37)17-7-14-37)43-34(28)44-18-19-46(35(47)23(2)38)26(21-44)12-15-41/h1,4-5,8-11,20,26H,2,6-7,12-14,16-19,21-22H2/t26-/m0/s1
InChIKey
PSTLLABDLNMWBW-SANMLTNESA-N
Chemical Structure
2D Structure
2D structure of Krasg12C IN-17
CAS: 2966924-23-0
CID: 169131470
Formula: C37H33F3N6O2
MW: 650.7
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight650.7
XLogP36.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count10
Rotatable Bond Count8
Exact Mass650.26170880
Monoisotopic Mass650.26170880
Topological Polar Surface Area85.6 Ų
Heavy Atom Count48
Formal Charge0
Complexity1300
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-179404KRASG12C IN-18
HY-173047KRASG12C IN-15
HY-159163KRASG12C IN-12
HY-164493-01KRASG12C IN-13
HY-179484KRASG12C IN-19
HY-168013KRASG12C IN-14
HY-168919KRASG12C IN-16
HY-173252KRASG12C ligand-1
HY-P705349-01HLA-A*0301 KRASG12C Complex, Human (Biotinylated, VVGACGVGK, HEK293, His-Avi)
HY-P705350-01HLA-A*0301 KRASG12C Complex, Human (Biotinylated, VVVGACGVGK, HEK293, His-Avi)

Alternative Products

CatalogName
GTR19273756-01KRASG12C IN-17
T205253-01KRASG12C IN-16
T200204-01KRASG12C IN-14
GTR19239280-01KRASG12C IN-13
GTR19238158-01KRASG12C IN-12
T75119-01KRASG12C IN-2
MBS5817042KRASG12C IN-2
GTR19274073-01KRASG12C IN-18
T205541-01KRASG12C IN-15
GTR19274329-01KRASG12C IN-19

Popular Products